ARTICLE | Company News
Phosphate Therapeutics, Medical Research Council deal
March 12, 2012 7:00 AM UTC
The Medical Research Council granted Phosphate exclusive, worldwide rights to PT20, a phosphate binder. MRC received an undisclosed equity stake and is eligible for milestones, plus single-digit roya...